Merit Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $243K | Sell |
462
-1,167
| -72% | -$613K | ﹤0.01% | 1448 |
|
|
2025
Q1 | $1.03M | Buy |
1,629
+761
| +88% | +$483K | 0.02% | 640 |
|
|
2024
Q4 | $618K | Buy |
868
+71
| +9% | +$50.5K | 0.01% | 646 |
|
|
2024
Q3 | $837K | Sell |
797
-79
| -9% | -$83K | 0.02% | 457 |
|
|
2024
Q2 | $920K | Buy |
876
+153
| +21% | +$161K | 0.02% | 437 |
|
|
2024
Q1 | $691K | Buy |
723
+396
| +121% | +$379K | 0.02% | 498 |
|
|
2023
Q4 | $287K | Sell |
327
-379
| -54% | -$332K | 0.01% | 636 |
|
|
2023
Q3 | $581K | Buy |
706
+16
| +2% | +$13.2K | 0.02% | 424 |
|
|
2023
Q2 | $495K | Buy |
690
+332
| +93% | +$238K | 0.02% | 470 |
|
|
2023
Q1 | $294K | Buy |
+358
| New | +$294K | 0.01% | 513 |
|
|
2020
Q3 | – | Sell |
-337
| Closed | -$210K | – | 233 |
|
|
2020
Q2 | $210K | Buy |
+337
| New | +$210K | 0.02% | 199 |
|